PMID: 8971403Dec 1, 1996Paper

Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches

Bone Marrow Transplantation
M Haskins

Abstract

A large series of animal models of human lysosomal storage diseases has undergone bone marrow transplantation (BMT) to evaluate this approach to providing a source of normal lysosomal hydrolases for therapy. The relative success of this approach appears to be dependent on the age at transplant and the specific disease being treated. The variability in results between different diseases may be due to the observation that the amount of each specific enzyme secreted by bone marrow and bone marrow-derived cells varies, and because different diseases have different organ systems which are affected, with particular emphasis on the central nervous system pathology.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Anales españoles de pediatría
M E Cela de JuliánJ Gil Herrera
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S C Gulati, C Van Poznak
International Journal of Hematology
T Masaoka
© 2021 Meta ULC. All rights reserved